| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Zebrafish | 84 | 2024 | 2992 | 5.680 |
Why?
|
| Cardiomyopathy, Dilated | 22 | 2024 | 818 | 4.120 |
Why?
|
| Zebrafish Proteins | 28 | 2024 | 1006 | 3.040 |
Why?
|
| Drug Discovery | 10 | 2021 | 1044 | 2.340 |
Why?
|
| Cardiomyopathies | 20 | 2024 | 1945 | 2.010 |
Why?
|
| Cardiomyopathy, Hypertrophic | 26 | 2023 | 1309 | 2.010 |
Why?
|
| Heart | 34 | 2024 | 4382 | 1.960 |
Why?
|
| Myocytes, Cardiac | 26 | 2023 | 1655 | 1.950 |
Why?
|
| Long QT Syndrome | 8 | 2014 | 465 | 1.600 |
Why?
|
| Genetic Testing | 20 | 2022 | 3529 | 1.510 |
Why?
|
| Atrial Fibrillation | 24 | 2023 | 5105 | 1.450 |
Why?
|
| Lamin Type A | 9 | 2024 | 187 | 1.420 |
Why?
|
| Models, Animal | 12 | 2017 | 2112 | 1.360 |
Why?
|
| Cardiovascular Diseases | 25 | 2023 | 15394 | 1.330 |
Why?
|
| Myocardium | 24 | 2024 | 4690 | 1.230 |
Why?
|
| Heart Conduction System | 6 | 2015 | 1011 | 1.190 |
Why?
|
| Arrhythmias, Cardiac | 12 | 2021 | 2248 | 1.170 |
Why?
|
| Death, Sudden, Cardiac | 9 | 2023 | 1553 | 1.120 |
Why?
|
| Potassium Channels, Voltage-Gated | 8 | 2010 | 141 | 1.120 |
Why?
|
| Cyanides | 6 | 2023 | 82 | 1.080 |
Why?
|
| Brugada Syndrome | 2 | 2023 | 95 | 1.010 |
Why?
|
| Genomics | 14 | 2022 | 5788 | 1.010 |
Why?
|
| Sarcomeres | 7 | 2019 | 367 | 1.000 |
Why?
|
| Phenotype | 33 | 2023 | 16533 | 0.980 |
Why?
|
| Systems Biology | 3 | 2020 | 482 | 0.930 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 7 | 2014 | 162 | 0.920 |
Why?
|
| Indazoles | 2 | 2022 | 302 | 0.910 |
Why?
|
| Heart Failure | 18 | 2024 | 11593 | 0.880 |
Why?
|
| Heart Block | 7 | 2013 | 392 | 0.850 |
Why?
|
| Mutation | 42 | 2024 | 29928 | 0.840 |
Why?
|
| Ethylenediamines | 1 | 2022 | 57 | 0.830 |
Why?
|
| Muscle Proteins | 7 | 2015 | 1150 | 0.800 |
Why?
|
| Cardiovascular System | 7 | 2021 | 835 | 0.800 |
Why?
|
| Toxicology | 1 | 2022 | 102 | 0.790 |
Why?
|
| Biomedical Research | 7 | 2019 | 3416 | 0.770 |
Why?
|
| Genetic Predisposition to Disease | 35 | 2023 | 17767 | 0.750 |
Why?
|
| Drug Evaluation, Preclinical | 9 | 2019 | 1335 | 0.740 |
Why?
|
| Cardiography, Impedance | 1 | 2020 | 40 | 0.730 |
Why?
|
| Animals | 116 | 2024 | 167777 | 0.730 |
Why?
|
| Myosin Light Chains | 2 | 2019 | 121 | 0.710 |
Why?
|
| Gene Expression Regulation, Developmental | 18 | 2024 | 3602 | 0.700 |
Why?
|
| Molecular Diagnostic Techniques | 3 | 2016 | 610 | 0.680 |
Why?
|
| Cardiac Output | 2 | 2021 | 837 | 0.670 |
Why?
|
| Cardiology | 5 | 2016 | 1667 | 0.670 |
Why?
|
| Friedreich Ataxia | 2 | 2018 | 77 | 0.670 |
Why?
|
| Academies and Institutes | 2 | 2019 | 318 | 0.660 |
Why?
|
| Embryo, Nonmammalian | 19 | 2016 | 900 | 0.650 |
Why?
|
| Humans | 222 | 2024 | 757650 | 0.640 |
Why?
|
| Potassium Cyanide | 1 | 2018 | 17 | 0.630 |
Why?
|
| Stroke Volume | 11 | 2024 | 5460 | 0.630 |
Why?
|
| Genetic Markers | 6 | 2014 | 2608 | 0.620 |
Why?
|
| Medical History Taking | 3 | 2018 | 772 | 0.610 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2018 | 63 | 0.600 |
Why?
|
| Animals, Genetically Modified | 16 | 2020 | 1553 | 0.600 |
Why?
|
| Industry | 1 | 2019 | 361 | 0.570 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2016 | 791 | 0.540 |
Why?
|
| Software Design | 1 | 2016 | 171 | 0.530 |
Why?
|
| Heart Atria | 7 | 2024 | 1344 | 0.510 |
Why?
|
| Cardiovascular Agents | 4 | 2019 | 839 | 0.510 |
Why?
|
| Electrocardiography | 14 | 2024 | 6363 | 0.500 |
Why?
|
| Genetic Variation | 13 | 2020 | 6549 | 0.500 |
Why?
|
| Amyloidosis | 6 | 2022 | 817 | 0.500 |
Why?
|
| Heart Arrest | 2 | 2023 | 1494 | 0.490 |
Why?
|
| Myocardial Contraction | 7 | 2014 | 1516 | 0.490 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2023 | 1842 | 0.490 |
Why?
|
| Nadolol | 1 | 2014 | 29 | 0.470 |
Why?
|
| Transcription Factors | 17 | 2024 | 12092 | 0.470 |
Why?
|
| Calcium Channels, L-Type | 2 | 2019 | 240 | 0.470 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2013 | 43 | 0.460 |
Why?
|
| alpha-Galactosidase | 1 | 2014 | 55 | 0.450 |
Why?
|
| Monitoring, Physiologic | 1 | 2021 | 1780 | 0.450 |
Why?
|
| Disease Models, Animal | 20 | 2023 | 18123 | 0.450 |
Why?
|
| RNA-Binding Proteins | 5 | 2022 | 1895 | 0.450 |
Why?
|
| Hyperglycemia | 2 | 2022 | 1367 | 0.450 |
Why?
|
| Chromosome Mapping | 14 | 2016 | 4624 | 0.450 |
Why?
|
| Program Development | 2 | 2019 | 1296 | 0.450 |
Why?
|
| Genome, Human | 7 | 2016 | 4414 | 0.450 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2015 | 534 | 0.450 |
Why?
|
| Metabolomics | 4 | 2018 | 1629 | 0.440 |
Why?
|
| Fabry Disease | 1 | 2014 | 85 | 0.430 |
Why?
|
| Coronary Disease | 4 | 2018 | 5913 | 0.430 |
Why?
|
| Regeneration | 7 | 2019 | 1505 | 0.430 |
Why?
|
| Sodium Channels | 4 | 2018 | 343 | 0.430 |
Why?
|
| Glycolipids | 1 | 2014 | 204 | 0.430 |
Why?
|
| Rare Diseases | 1 | 2018 | 618 | 0.430 |
Why?
|
| gamma Catenin | 3 | 2014 | 44 | 0.430 |
Why?
|
| Electric Conductivity | 4 | 2010 | 405 | 0.420 |
Why?
|
| Natriuretic Peptide, Brain | 5 | 2022 | 1704 | 0.420 |
Why?
|
| Terminology as Topic | 1 | 2020 | 1533 | 0.420 |
Why?
|
| Voltage-Sensitive Dye Imaging | 1 | 2012 | 31 | 0.410 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 697 | 0.410 |
Why?
|
| Sphingolipids | 1 | 2014 | 173 | 0.410 |
Why?
|
| Scleroderma, Systemic | 1 | 2016 | 344 | 0.410 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2015 | 601 | 0.400 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 1894 | 0.400 |
Why?
|
| Gene Knockdown Techniques | 6 | 2024 | 1609 | 0.390 |
Why?
|
| Pedigree | 23 | 2018 | 4578 | 0.390 |
Why?
|
| Medicine | 2 | 2017 | 940 | 0.390 |
Why?
|
| Defibrillators, Implantable | 3 | 2020 | 1487 | 0.390 |
Why?
|
| Polymorphism, Single Nucleotide | 13 | 2023 | 15773 | 0.380 |
Why?
|
| Antidotes | 4 | 2023 | 137 | 0.380 |
Why?
|
| Desmosomes | 3 | 2010 | 72 | 0.380 |
Why?
|
| Toxicity Tests | 1 | 2011 | 112 | 0.380 |
Why?
|
| Metabolome | 1 | 2018 | 982 | 0.380 |
Why?
|
| Genome | 3 | 2020 | 1739 | 0.380 |
Why?
|
| Coronary Artery Disease | 4 | 2019 | 6363 | 0.370 |
Why?
|
| Chromosomes, Human, Pair 12 | 2 | 2011 | 430 | 0.370 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2013 | 776 | 0.370 |
Why?
|
| Potassium Channels | 5 | 2018 | 534 | 0.370 |
Why?
|
| Hypertrophy, Left Ventricular | 6 | 2023 | 849 | 0.370 |
Why?
|
| Atrial Natriuretic Factor | 3 | 2018 | 350 | 0.360 |
Why?
|
| Natriuretic Peptides | 1 | 2011 | 155 | 0.360 |
Why?
|
| High-Throughput Screening Assays | 4 | 2019 | 933 | 0.360 |
Why?
|
| Atherosclerosis | 3 | 2024 | 3401 | 0.350 |
Why?
|
| Organogenesis | 2 | 2011 | 215 | 0.350 |
Why?
|
| Genome-Wide Association Study | 16 | 2023 | 12604 | 0.350 |
Why?
|
| Peripartum Period | 1 | 2011 | 137 | 0.350 |
Why?
|
| Luciferases | 1 | 2011 | 714 | 0.350 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2011 | 327 | 0.340 |
Why?
|
| DNA-Binding Proteins | 9 | 2024 | 9574 | 0.340 |
Why?
|
| User-Computer Interface | 1 | 2016 | 1397 | 0.340 |
Why?
|
| KCNQ1 Potassium Channel | 6 | 2019 | 102 | 0.340 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 6 | 2014 | 72 | 0.340 |
Why?
|
| Goiter | 1 | 2010 | 87 | 0.340 |
Why?
|
| Wnt Proteins | 3 | 2014 | 719 | 0.340 |
Why?
|
| Medical Informatics | 1 | 2016 | 732 | 0.330 |
Why?
|
| Psoriasis | 1 | 2017 | 938 | 0.330 |
Why?
|
| Hypertension | 6 | 2022 | 8502 | 0.330 |
Why?
|
| Vascular Diseases | 1 | 2017 | 1160 | 0.320 |
Why?
|
| Thrombosis | 2 | 2022 | 2930 | 0.320 |
Why?
|
| Organ Culture Techniques | 2 | 2014 | 794 | 0.320 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2023 | 1074 | 0.320 |
Why?
|
| Fellowships and Scholarships | 1 | 2017 | 1113 | 0.310 |
Why?
|
| Education, Medical | 2 | 2017 | 1725 | 0.310 |
Why?
|
| Hearing Loss, Sensorineural | 4 | 2010 | 781 | 0.310 |
Why?
|
| Genetic Linkage | 14 | 2006 | 2381 | 0.310 |
Why?
|
| Receptor, Notch1 | 2 | 2014 | 494 | 0.310 |
Why?
|
| Genes, Regulator | 1 | 2009 | 374 | 0.310 |
Why?
|
| Desmoplakins | 2 | 2019 | 62 | 0.310 |
Why?
|
| Family | 4 | 2019 | 3188 | 0.310 |
Why?
|
| Ion Channel Gating | 1 | 2010 | 435 | 0.300 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 1957 | 0.300 |
Why?
|
| Blood Circulation | 1 | 2008 | 249 | 0.290 |
Why?
|
| Female | 92 | 2024 | 389985 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2006 | 276 | 0.290 |
Why?
|
| Male | 92 | 2024 | 358227 | 0.280 |
Why?
|
| Neovascularization, Physiologic | 5 | 2018 | 1332 | 0.280 |
Why?
|
| American Heart Association | 6 | 2018 | 1039 | 0.280 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2011 | 515 | 0.280 |
Why?
|
| Genetic Association Studies | 4 | 2020 | 2717 | 0.270 |
Why?
|
| Middle Aged | 64 | 2024 | 219219 | 0.270 |
Why?
|
| Heart Rate | 6 | 2020 | 4166 | 0.270 |
Why?
|
| Neuregulins | 1 | 2006 | 36 | 0.270 |
Why?
|
| Molecular Targeted Therapy | 3 | 2016 | 2796 | 0.270 |
Why?
|
| Genetics, Medical | 1 | 2009 | 336 | 0.270 |
Why?
|
| Membrane Potentials | 1 | 2009 | 1094 | 0.260 |
Why?
|
| Glyoxylates | 2 | 2023 | 11 | 0.260 |
Why?
|
| Receptors, Notch | 3 | 2015 | 743 | 0.250 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 2 | 2019 | 431 | 0.250 |
Why?
|
| Aging, Premature | 1 | 2005 | 44 | 0.250 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 5325 | 0.250 |
Why?
|
| Genotype | 11 | 2019 | 12951 | 0.250 |
Why?
|
| Electrophysiological Phenomena | 3 | 2012 | 308 | 0.250 |
Why?
|
| Forecasting | 5 | 2016 | 2919 | 0.240 |
Why?
|
| Disease | 2 | 2017 | 671 | 0.240 |
Why?
|
| Quantitative Trait Loci | 3 | 2023 | 2100 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2003 | 373 | 0.240 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2007 | 1651 | 0.240 |
Why?
|
| Membrane Proteins | 5 | 2020 | 7841 | 0.230 |
Why?
|
| Action Potentials | 5 | 2023 | 1816 | 0.230 |
Why?
|
| Homeodomain Proteins | 5 | 2023 | 2412 | 0.230 |
Why?
|
| Signal Transduction | 12 | 2016 | 23342 | 0.230 |
Why?
|
| Polymorphism, Genetic | 7 | 2009 | 4283 | 0.230 |
Why?
|
| Response Elements | 1 | 2005 | 308 | 0.230 |
Why?
|
| Acute Coronary Syndrome | 2 | 2016 | 2180 | 0.230 |
Why?
|
| Renin | 2 | 2017 | 635 | 0.230 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 2 | 2014 | 22 | 0.230 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2023 | 12076 | 0.220 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2022 | 530 | 0.220 |
Why?
|
| Chromosome Disorders | 4 | 2014 | 499 | 0.220 |
Why?
|
| Wolff-Parkinson-White Syndrome | 3 | 2005 | 116 | 0.220 |
Why?
|
| Disease Management | 3 | 2020 | 2495 | 0.220 |
Why?
|
| Cadherins | 3 | 2024 | 898 | 0.220 |
Why?
|
| Physical Chromosome Mapping | 1 | 2003 | 182 | 0.210 |
Why?
|
| Penetrance | 4 | 2010 | 388 | 0.210 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2002 | 51 | 0.210 |
Why?
|
| Bradycardia | 2 | 2011 | 299 | 0.210 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2022 | 29 | 0.210 |
Why?
|
| Ventricular Function, Left | 5 | 2024 | 3858 | 0.210 |
Why?
|
| Calcium | 6 | 2022 | 5722 | 0.210 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2002 | 69 | 0.210 |
Why?
|
| Cation Transport Proteins | 2 | 2003 | 324 | 0.200 |
Why?
|
| Plakophilins | 3 | 2014 | 32 | 0.200 |
Why?
|
| Heart Diseases | 4 | 2024 | 2780 | 0.200 |
Why?
|
| Heart Valve Diseases | 3 | 2015 | 1033 | 0.190 |
Why?
|
| Pituitary Gland | 1 | 2024 | 637 | 0.190 |
Why?
|
| Ventricular Remodeling | 3 | 2023 | 1256 | 0.190 |
Why?
|
| Co-Repressor Proteins | 1 | 2022 | 191 | 0.190 |
Why?
|
| Poisoning | 1 | 2023 | 252 | 0.190 |
Why?
|
| Longevity | 3 | 2023 | 1050 | 0.190 |
Why?
|
| Publishing | 1 | 2008 | 832 | 0.190 |
Why?
|
| Specimen Handling | 1 | 2006 | 703 | 0.190 |
Why?
|
| Receptors, Lysophospholipid | 1 | 2020 | 40 | 0.190 |
Why?
|
| Platinum | 1 | 2022 | 219 | 0.190 |
Why?
|
| RNA Splicing | 4 | 2017 | 913 | 0.180 |
Why?
|
| DNA | 3 | 2014 | 7199 | 0.180 |
Why?
|
| Myocardial Infarction | 4 | 2023 | 11422 | 0.180 |
Why?
|
| Cardiomegaly | 3 | 2022 | 591 | 0.180 |
Why?
|
| Aneurysm, Ruptured | 2 | 2016 | 459 | 0.180 |
Why?
|
| Adult | 50 | 2024 | 219747 | 0.180 |
Why?
|
| Risk Factors | 23 | 2023 | 73716 | 0.180 |
Why?
|
| Intracranial Aneurysm | 3 | 2016 | 1276 | 0.180 |
Why?
|
| Feasibility Studies | 3 | 2021 | 5195 | 0.180 |
Why?
|
| Mutation, Missense | 7 | 2017 | 2565 | 0.180 |
Why?
|
| Body Patterning | 5 | 2018 | 632 | 0.180 |
Why?
|
| Algorithms | 10 | 2020 | 13952 | 0.170 |
Why?
|
| Tubulin | 1 | 2023 | 692 | 0.170 |
Why?
|
| Rabbits | 7 | 2022 | 4771 | 0.170 |
Why?
|
| Microvessels | 1 | 2024 | 572 | 0.170 |
Why?
|
| Therapies, Investigational | 1 | 2020 | 111 | 0.170 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2022 | 628 | 0.170 |
Why?
|
| Lod Score | 6 | 2006 | 602 | 0.170 |
Why?
|
| MAP Kinase Signaling System | 3 | 2015 | 1477 | 0.170 |
Why?
|
| Registries | 1 | 2015 | 8164 | 0.160 |
Why?
|
| Endothelium, Vascular | 6 | 2016 | 4429 | 0.160 |
Why?
|
| Echocardiography | 6 | 2022 | 4962 | 0.160 |
Why?
|
| Early Diagnosis | 1 | 2024 | 1177 | 0.160 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2019 | 82 | 0.160 |
Why?
|
| Case-Control Studies | 13 | 2020 | 22024 | 0.160 |
Why?
|
| Cell Proliferation | 9 | 2019 | 10416 | 0.160 |
Why?
|
| Connexin 43 | 1 | 2019 | 200 | 0.160 |
Why?
|
| United States | 18 | 2019 | 71907 | 0.160 |
Why?
|
| Pharmaceutical Preparations | 2 | 2021 | 1088 | 0.160 |
Why?
|
| Online Systems | 1 | 2019 | 181 | 0.160 |
Why?
|
| Information Dissemination | 3 | 2017 | 1128 | 0.160 |
Why?
|
| Sodium-Glucose Transporter 1 | 1 | 2018 | 108 | 0.160 |
Why?
|
| Hematology | 1 | 2022 | 241 | 0.160 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2019 | 122 | 0.160 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2022 | 850 | 0.150 |
Why?
|
| Exercise Tolerance | 3 | 2024 | 830 | 0.150 |
Why?
|
| Ion Channels | 2 | 2022 | 1043 | 0.150 |
Why?
|
| Lysophospholipids | 1 | 2020 | 338 | 0.150 |
Why?
|
| Risk Assessment | 11 | 2022 | 23819 | 0.150 |
Why?
|
| Myoblasts, Cardiac | 1 | 2018 | 21 | 0.150 |
Why?
|
| Syndrome | 7 | 2011 | 3261 | 0.150 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2016 | 1031 | 0.150 |
Why?
|
| Telemedicine | 3 | 2020 | 3016 | 0.150 |
Why?
|
| Artificial Intelligence | 4 | 2024 | 2547 | 0.150 |
Why?
|
| Interdisciplinary Studies | 1 | 2018 | 86 | 0.150 |
Why?
|
| Microtubules | 1 | 2023 | 1072 | 0.150 |
Why?
|
| Endosomes | 1 | 2020 | 519 | 0.150 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2018 | 87 | 0.150 |
Why?
|
| Intestinal Absorption | 1 | 2018 | 400 | 0.140 |
Why?
|
| Periodicals as Topic | 1 | 2008 | 1459 | 0.140 |
Why?
|
| HEK293 Cells | 8 | 2021 | 4258 | 0.140 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2018 | 134 | 0.140 |
Why?
|
| Disease Susceptibility | 2 | 2022 | 1788 | 0.140 |
Why?
|
| Wolffian Ducts | 1 | 2017 | 27 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2018 | 1889 | 0.140 |
Why?
|
| Aged | 33 | 2024 | 167889 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 4 | 2 | 2009 | 377 | 0.140 |
Why?
|
| Myofibrils | 1 | 2017 | 141 | 0.140 |
Why?
|
| Amino Acid Sequence | 10 | 2017 | 13447 | 0.140 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2019 | 241 | 0.140 |
Why?
|
| Gene Frequency | 8 | 2020 | 3612 | 0.140 |
Why?
|
| Myosins | 4 | 1994 | 405 | 0.140 |
Why?
|
| Tryptophan-tRNA Ligase | 1 | 2016 | 16 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 5 | 2017 | 4710 | 0.140 |
Why?
|
| Molecular Sequence Data | 17 | 2015 | 17617 | 0.140 |
Why?
|
| Gene Expression Regulation | 7 | 2024 | 11893 | 0.140 |
Why?
|
| Cardiotoxins | 2 | 2013 | 36 | 0.140 |
Why?
|
| Blood Vessels | 3 | 2010 | 1112 | 0.140 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 802 | 0.140 |
Why?
|
| Biological Evolution | 1 | 2022 | 1074 | 0.140 |
Why?
|
| Mammals | 3 | 2023 | 1132 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 1 | 2022 | 1342 | 0.140 |
Why?
|
| Carrier Proteins | 4 | 2017 | 4937 | 0.130 |
Why?
|
| Models, Cardiovascular | 2 | 2020 | 970 | 0.130 |
Why?
|
| Medication Reconciliation | 1 | 2018 | 153 | 0.130 |
Why?
|
| Transcription, Genetic | 6 | 2017 | 7590 | 0.130 |
Why?
|
| Predictive Value of Tests | 5 | 2020 | 15209 | 0.130 |
Why?
|
| Noonan Syndrome | 1 | 2017 | 120 | 0.130 |
Why?
|
| Neuregulin-1 | 2 | 2015 | 135 | 0.130 |
Why?
|
| Oligonucleotides, Antisense | 3 | 2011 | 459 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2021 | 3227 | 0.130 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2015 | 17 | 0.130 |
Why?
|
| Thrombospondins | 1 | 2016 | 193 | 0.130 |
Why?
|
| Health Status | 1 | 2009 | 4066 | 0.130 |
Why?
|
| Cystine-Knot Miniproteins | 1 | 2015 | 4 | 0.130 |
Why?
|
| Immunoglobulin Light Chains | 2 | 2014 | 286 | 0.130 |
Why?
|
| Pharmacists | 1 | 2018 | 258 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 1999 | 310 | 0.130 |
Why?
|
| Mice | 20 | 2024 | 81107 | 0.130 |
Why?
|
| Physical Examination | 1 | 2022 | 1244 | 0.130 |
Why?
|
| Cell Shape | 1 | 2017 | 371 | 0.130 |
Why?
|
| Ubiquitin | 1 | 2020 | 837 | 0.130 |
Why?
|
| Education, Medical, Graduate | 2 | 2019 | 2355 | 0.130 |
Why?
|
| Base Sequence | 14 | 2012 | 12437 | 0.130 |
Why?
|
| Professional Role | 1 | 2018 | 309 | 0.130 |
Why?
|
| Glucose Tolerance Test | 1 | 2018 | 1173 | 0.130 |
Why?
|
| Pilot Projects | 7 | 2020 | 8551 | 0.120 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2015 | 664 | 0.120 |
Why?
|
| Nuclear Proteins | 5 | 2020 | 5786 | 0.120 |
Why?
|
| Lipoproteins, LDL | 1 | 2018 | 640 | 0.120 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2021 | 803 | 0.120 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 9404 | 0.120 |
Why?
|
| Anthelmintics | 1 | 2015 | 82 | 0.120 |
Why?
|
| Actins | 4 | 2017 | 2049 | 0.120 |
Why?
|
| Organisms, Genetically Modified | 2 | 2005 | 63 | 0.120 |
Why?
|
| KCNQ Potassium Channels | 2 | 2004 | 15 | 0.120 |
Why?
|
| Primary Health Care | 3 | 2017 | 4651 | 0.120 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2024 | 2115 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 1 | 7 | 2013 | 635 | 0.120 |
Why?
|
| Diffusion of Innovation | 2 | 2016 | 727 | 0.120 |
Why?
|
| T-Box Domain Proteins | 2 | 2015 | 468 | 0.120 |
Why?
|
| Sequence Analysis | 1 | 2015 | 240 | 0.120 |
Why?
|
| Genes, ras | 1 | 2017 | 654 | 0.120 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2013 | 28 | 0.120 |
Why?
|
| C-Reactive Protein | 1 | 2006 | 3811 | 0.120 |
Why?
|
| Intercellular Junctions | 1 | 2014 | 197 | 0.110 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2017 | 540 | 0.110 |
Why?
|
| Smad2 Protein | 1 | 2014 | 145 | 0.110 |
Why?
|
| Quality of Life | 3 | 2023 | 13265 | 0.110 |
Why?
|
| Data Mining | 2 | 2016 | 551 | 0.110 |
Why?
|
| Chemical Engineering | 1 | 2013 | 15 | 0.110 |
Why?
|
| Blood Pressure | 4 | 2019 | 8452 | 0.110 |
Why?
|
| Government Programs | 1 | 2016 | 279 | 0.110 |
Why?
|
| Apolipoproteins | 1 | 2016 | 319 | 0.110 |
Why?
|
| Kidney Glomerulus | 2 | 2016 | 568 | 0.110 |
Why?
|
| Myocardial Ischemia | 1 | 2024 | 2108 | 0.110 |
Why?
|
| Smad1 Protein | 1 | 2013 | 81 | 0.110 |
Why?
|
| Cardiotonic Agents | 2 | 2014 | 539 | 0.110 |
Why?
|
| Heart Ventricles | 4 | 2015 | 3806 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2023 | 2859 | 0.110 |
Why?
|
| Environment | 1 | 2019 | 1118 | 0.110 |
Why?
|
| Endothelial Cells | 5 | 2020 | 3533 | 0.110 |
Why?
|
| Plant Proteins | 1 | 2015 | 369 | 0.110 |
Why?
|
| Parathion | 1 | 2012 | 14 | 0.110 |
Why?
|
| Atrioventricular Block | 1 | 2014 | 120 | 0.110 |
Why?
|
| Child | 19 | 2023 | 79787 | 0.110 |
Why?
|
| Genes, Neoplasm | 1 | 2014 | 370 | 0.110 |
Why?
|
| Animals, Newborn | 5 | 2018 | 2673 | 0.110 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2018 | 993 | 0.110 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2015 | 268 | 0.100 |
Why?
|
| Adolescent | 23 | 2023 | 87832 | 0.100 |
Why?
|
| Health Education | 1 | 2019 | 1049 | 0.100 |
Why?
|
| Riboflavin | 1 | 2013 | 105 | 0.100 |
Why?
|
| Access to Information | 1 | 2015 | 316 | 0.100 |
Why?
|
| Heart Defects, Congenital | 4 | 2018 | 4673 | 0.100 |
Why?
|
| Swine | 2 | 2023 | 5892 | 0.100 |
Why?
|
| Drug Design | 2 | 2022 | 1049 | 0.100 |
Why?
|
| Renin-Angiotensin System | 1 | 2017 | 733 | 0.100 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2014 | 397 | 0.100 |
Why?
|
| Aneurysm | 1 | 2015 | 336 | 0.100 |
Why?
|
| Cardiovascular Physiological Phenomena | 2 | 2012 | 239 | 0.100 |
Why?
|
| Databases, Factual | 2 | 2019 | 7926 | 0.100 |
Why?
|
| Carcinogenicity Tests | 1 | 2011 | 38 | 0.100 |
Why?
|
| Butadienes | 1 | 2011 | 107 | 0.100 |
Why?
|
| Stroke | 4 | 2023 | 9695 | 0.100 |
Why?
|
| Receptors, LDL | 1 | 2014 | 485 | 0.100 |
Why?
|
| Causality | 1 | 2018 | 1241 | 0.100 |
Why?
|
| Apoptosis | 3 | 2019 | 9469 | 0.100 |
Why?
|
| Research Report | 1 | 2015 | 367 | 0.100 |
Why?
|
| Histones | 1 | 2022 | 2577 | 0.100 |
Why?
|
| Pharmacokinetics | 1 | 2011 | 86 | 0.100 |
Why?
|
| Troponin T | 3 | 2018 | 761 | 0.100 |
Why?
|
| Drug Industry | 1 | 2018 | 787 | 0.100 |
Why?
|
| Hydroxamic Acids | 2 | 2011 | 481 | 0.090 |
Why?
|
| Doxorubicin | 2 | 2020 | 2211 | 0.090 |
Why?
|
| Heart Valves | 1 | 2013 | 284 | 0.090 |
Why?
|
| Intracranial Arterial Diseases | 1 | 2011 | 22 | 0.090 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 664 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 15782 | 0.090 |
Why?
|
| Mechanical Phenomena | 1 | 2012 | 140 | 0.090 |
Why?
|
| Aged, 80 and over | 12 | 2020 | 58559 | 0.090 |
Why?
|
| Outpatients | 1 | 2019 | 1590 | 0.090 |
Why?
|
| Peptide Fragments | 3 | 2017 | 5098 | 0.090 |
Why?
|
| Troponin C | 1 | 2010 | 24 | 0.090 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 2012 | 864 | 0.090 |
Why?
|
| Cisplatin | 1 | 2017 | 1647 | 0.090 |
Why?
|
| Anticholesteremic Agents | 1 | 2018 | 963 | 0.090 |
Why?
|
| Research Design | 3 | 2019 | 6151 | 0.090 |
Why?
|
| Prognosis | 7 | 2019 | 29493 | 0.090 |
Why?
|
| Genetic Loci | 2 | 2017 | 2612 | 0.090 |
Why?
|
| Dyslipidemias | 1 | 2018 | 867 | 0.090 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2010 | 102 | 0.090 |
Why?
|
| Tunisia | 1 | 2010 | 36 | 0.090 |
Why?
|
| GATA Transcription Factors | 1 | 2010 | 29 | 0.090 |
Why?
|
| Patient Participation | 1 | 2019 | 1435 | 0.090 |
Why?
|
| Antineoplastic Agents | 2 | 2024 | 13603 | 0.090 |
Why?
|
| Endocardial Cushions | 1 | 2009 | 12 | 0.090 |
Why?
|
| Chromatin | 1 | 2022 | 2938 | 0.090 |
Why?
|
| Protein Transport | 3 | 2021 | 1963 | 0.090 |
Why?
|
| Trans-Activators | 3 | 2008 | 2859 | 0.090 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2010 | 38 | 0.090 |
Why?
|
| Genetic Counseling | 1 | 2014 | 624 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 3 | 2017 | 5779 | 0.090 |
Why?
|
| Aorta | 2 | 2015 | 2037 | 0.090 |
Why?
|
| Feedback, Physiological | 1 | 2012 | 475 | 0.090 |
Why?
|
| Mass Screening | 2 | 2019 | 5413 | 0.090 |
Why?
|
| ras Proteins | 1 | 2015 | 1050 | 0.080 |
Why?
|
| Cyclic AMP | 1 | 2013 | 1455 | 0.080 |
Why?
|
| Chondroitin Sulfates | 1 | 2009 | 174 | 0.080 |
Why?
|
| Angiopoietin-1 | 1 | 2010 | 122 | 0.080 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2015 | 502 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2018 | 1884 | 0.080 |
Why?
|
| Muscle, Skeletal | 3 | 2015 | 4902 | 0.080 |
Why?
|
| Calcium Signaling | 2 | 2011 | 732 | 0.080 |
Why?
|
| Lysosomes | 1 | 2014 | 919 | 0.080 |
Why?
|
| Coronary Circulation | 2 | 2007 | 1561 | 0.080 |
Why?
|
| Alternative Splicing | 2 | 2011 | 1091 | 0.080 |
Why?
|
| Young Adult | 13 | 2022 | 58764 | 0.080 |
Why?
|
| Computational Biology | 3 | 2017 | 3501 | 0.080 |
Why?
|
| Cohort Studies | 8 | 2017 | 41198 | 0.080 |
Why?
|
| Cell Line | 3 | 2019 | 15594 | 0.080 |
Why?
|
| Catheter Ablation | 3 | 2018 | 2741 | 0.080 |
Why?
|
| Spliceosomes | 1 | 2009 | 129 | 0.080 |
Why?
|
| Therapeutics | 1 | 2009 | 113 | 0.080 |
Why?
|
| Tryptophan | 1 | 2010 | 479 | 0.080 |
Why?
|
| Teaching | 1 | 2016 | 1168 | 0.080 |
Why?
|
| Atrioventricular Node | 1 | 2009 | 180 | 0.080 |
Why?
|
| Policy Making | 1 | 2012 | 538 | 0.080 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2013 | 841 | 0.080 |
Why?
|
| Molecular Sequence Annotation | 1 | 2010 | 524 | 0.080 |
Why?
|
| Carcinoma, Medullary | 1 | 2008 | 115 | 0.080 |
Why?
|
| Amyloid | 1 | 2013 | 840 | 0.080 |
Why?
|
| Death, Sudden | 1 | 2010 | 302 | 0.070 |
Why?
|
| Drug Delivery Systems | 2 | 2011 | 2211 | 0.070 |
Why?
|
| Risk Management | 1 | 2011 | 557 | 0.070 |
Why?
|
| Cell Movement | 3 | 2015 | 5201 | 0.070 |
Why?
|
| Pharmacogenetics | 3 | 2020 | 675 | 0.070 |
Why?
|
| Connective Tissue Diseases | 1 | 2011 | 285 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2014 | 3090 | 0.070 |
Why?
|
| Genes, Reporter | 1 | 2011 | 1527 | 0.070 |
Why?
|
| Hematopoietic System | 1 | 2008 | 109 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 1135 | 0.070 |
Why?
|
| Software | 3 | 2016 | 4416 | 0.070 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2008 | 504 | 0.070 |
Why?
|
| Hyperplasia | 1 | 2011 | 1153 | 0.070 |
Why?
|
| Aortic Diseases | 1 | 2013 | 735 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 10135 | 0.070 |
Why?
|
| Protein Isoforms | 2 | 2010 | 1694 | 0.070 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2009 | 361 | 0.070 |
Why?
|
| Species Specificity | 2 | 2015 | 2416 | 0.070 |
Why?
|
| MicroRNAs | 2 | 2013 | 3782 | 0.070 |
Why?
|
| Desmocollins | 1 | 2006 | 11 | 0.070 |
Why?
|
| Physical Conditioning, Animal | 1 | 2010 | 364 | 0.070 |
Why?
|
| Arginine | 1 | 2010 | 933 | 0.070 |
Why?
|
| Muscles | 1 | 2011 | 1575 | 0.070 |
Why?
|
| Double-Blind Method | 4 | 2024 | 12260 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2008 | 225 | 0.070 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2011 | 772 | 0.070 |
Why?
|
| Nitriles | 1 | 2011 | 956 | 0.070 |
Why?
|
| Autophagy | 1 | 2014 | 1322 | 0.070 |
Why?
|
| Codon | 1 | 2008 | 601 | 0.070 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1992 | 1093 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 2015 | 2131 | 0.070 |
Why?
|
| Multifactorial Inheritance | 1 | 2014 | 1365 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 7366 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 2 | 2017 | 2057 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 3 | 2014 | 4406 | 0.070 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2013 | 1044 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2015 | 2145 | 0.070 |
Why?
|
| Caenorhabditis elegans | 1 | 2015 | 1443 | 0.070 |
Why?
|
| Luciferases, Renilla | 1 | 2005 | 21 | 0.070 |
Why?
|
| In Situ Hybridization | 4 | 2013 | 1900 | 0.070 |
Why?
|
| Tropomyosin | 3 | 1995 | 104 | 0.070 |
Why?
|
| Blood Cells | 2 | 2023 | 305 | 0.060 |
Why?
|
| Luciferases, Firefly | 1 | 2005 | 37 | 0.060 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2008 | 477 | 0.060 |
Why?
|
| Luminescent Agents | 1 | 2005 | 29 | 0.060 |
Why?
|
| Mitochondria | 2 | 2016 | 3584 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2013 | 2205 | 0.060 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2006 | 144 | 0.060 |
Why?
|
| Human Genome Project | 2 | 2017 | 199 | 0.060 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2008 | 350 | 0.060 |
Why?
|
| Gastrointestinal Tract | 1 | 2011 | 830 | 0.060 |
Why?
|
| Time Factors | 10 | 2019 | 39815 | 0.060 |
Why?
|
| Interdisciplinary Communication | 3 | 2016 | 931 | 0.060 |
Why?
|
| Lethal Dose 50 | 2 | 2017 | 72 | 0.060 |
Why?
|
| Renal Circulation | 1 | 2006 | 291 | 0.060 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 2047 | 0.060 |
Why?
|
| Ubiquitination | 2 | 2020 | 1008 | 0.060 |
Why?
|
| Hedgehog Proteins | 1 | 2010 | 768 | 0.060 |
Why?
|
| Pyrazoles | 1 | 2015 | 1994 | 0.060 |
Why?
|
| Protein Kinases | 1 | 2012 | 1610 | 0.060 |
Why?
|
| Treatment Outcome | 6 | 2024 | 64242 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2016 | 2082 | 0.060 |
Why?
|
| Ligands | 2 | 2022 | 3258 | 0.060 |
Why?
|
| Galectin 3 | 1 | 2006 | 240 | 0.060 |
Why?
|
| Inflammation | 3 | 2024 | 10718 | 0.060 |
Why?
|
| Ear, Inner | 1 | 2008 | 424 | 0.060 |
Why?
|
| Gene Dosage | 1 | 2009 | 1218 | 0.060 |
Why?
|
| Ultrasonography | 3 | 2007 | 5951 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2009 | 12047 | 0.060 |
Why?
|
| Endothelin-1 | 1 | 2006 | 302 | 0.060 |
Why?
|
| Haplotypes | 4 | 2007 | 2764 | 0.060 |
Why?
|
| Glucuronidase | 1 | 2005 | 202 | 0.060 |
Why?
|
| Genes, Dominant | 5 | 2000 | 862 | 0.060 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 2005 | 576 | 0.060 |
Why?
|
| Cloning, Organism | 1 | 2003 | 50 | 0.060 |
Why?
|
| MERRF Syndrome | 1 | 2003 | 4 | 0.060 |
Why?
|
| Systole | 1 | 2006 | 936 | 0.060 |
Why?
|
| Alleles | 4 | 2022 | 6894 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 10750 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2008 | 1135 | 0.060 |
Why?
|
| RNA Splice Sites | 2 | 2017 | 211 | 0.060 |
Why?
|
| Cells, Cultured | 6 | 2021 | 18941 | 0.050 |
Why?
|
| Cell Count | 2 | 2011 | 1835 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2015 | 3005 | 0.050 |
Why?
|
| Mitochondrial Myopathies | 1 | 2003 | 49 | 0.050 |
Why?
|
| Rats | 6 | 2022 | 23681 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 2013 | 2638 | 0.050 |
Why?
|
| Prevalence | 3 | 2011 | 15641 | 0.050 |
Why?
|
| Age of Onset | 4 | 2020 | 3296 | 0.050 |
Why?
|
| Ear | 1 | 2003 | 172 | 0.050 |
Why?
|
| Thyroidectomy | 1 | 2008 | 902 | 0.050 |
Why?
|
| Neutrophil Activation | 1 | 2023 | 181 | 0.050 |
Why?
|
| Receptors, Adrenergic | 1 | 2002 | 155 | 0.050 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2003 | 85 | 0.050 |
Why?
|
| Lamins | 2 | 2018 | 37 | 0.050 |
Why?
|
| Biological Assay | 1 | 2005 | 626 | 0.050 |
Why?
|
| Hypopituitarism | 1 | 2024 | 250 | 0.050 |
Why?
|
| Heart Transplantation | 2 | 2017 | 3220 | 0.050 |
Why?
|
| Growth Hormone | 1 | 2024 | 568 | 0.050 |
Why?
|
| Morbidity | 1 | 2008 | 1748 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2017 | 2753 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 2020 | 3069 | 0.050 |
Why?
|
| Homeostasis | 2 | 2018 | 3302 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2005 | 1164 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 3384 | 0.050 |
Why?
|
| Larva | 2 | 2015 | 507 | 0.050 |
Why?
|
| Anthracyclines | 1 | 2024 | 282 | 0.050 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1994 | 783 | 0.050 |
Why?
|
| Aortic Coarctation | 1 | 2004 | 282 | 0.050 |
Why?
|
| Phylogeny | 2 | 2022 | 2774 | 0.050 |
Why?
|
| Sulfides | 1 | 2022 | 170 | 0.050 |
Why?
|
| Verapamil | 1 | 2022 | 242 | 0.050 |
Why?
|
| Acidosis, Lactic | 1 | 2003 | 145 | 0.050 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2022 | 251 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2005 | 665 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2021 | 1240 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2016 | 4411 | 0.050 |
Why?
|
| Introns | 4 | 2010 | 978 | 0.050 |
Why?
|
| Immunoassay | 1 | 2005 | 746 | 0.050 |
Why?
|
| Pyruvic Acid | 1 | 2022 | 195 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2006 | 1955 | 0.050 |
Why?
|
| beta Catenin | 1 | 2006 | 1043 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 3709 | 0.050 |
Why?
|
| Pediatrics | 1 | 2016 | 3586 | 0.050 |
Why?
|
| Receptors, Angiotensin | 1 | 2021 | 141 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2003 | 785 | 0.050 |
Why?
|
| Desmin | 1 | 2000 | 99 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 1999 | 313 | 0.050 |
Why?
|
| DNA Mutational Analysis | 3 | 2017 | 4107 | 0.050 |
Why?
|
| Rats, Wistar | 2 | 2014 | 1844 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2013 | 3560 | 0.050 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2020 | 77 | 0.050 |
Why?
|
| Canada | 2 | 2019 | 2108 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2008 | 2903 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2007 | 1846 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 1992 | 4451 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 22008 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2024 | 675 | 0.040 |
Why?
|
| Linear Models | 3 | 2017 | 5857 | 0.040 |
Why?
|
| Norepinephrine | 1 | 2002 | 897 | 0.040 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2020 | 169 | 0.040 |
Why?
|
| Age Factors | 4 | 2019 | 18328 | 0.040 |
Why?
|
| Genetic Techniques | 2 | 2000 | 427 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2008 | 1594 | 0.040 |
Why?
|
| Sex Factors | 3 | 2007 | 10497 | 0.040 |
Why?
|
| Bundle of His | 1 | 1999 | 89 | 0.040 |
Why?
|
| Hemodynamics | 2 | 2023 | 4156 | 0.040 |
Why?
|
| Fibrosis | 1 | 2006 | 2038 | 0.040 |
Why?
|
| Follow-Up Studies | 7 | 2019 | 39018 | 0.040 |
Why?
|
| Electrophysiology | 2 | 2014 | 1263 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2003 | 939 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2008 | 2533 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2009 | 3441 | 0.040 |
Why?
|
| Pacemaker, Artificial | 2 | 2017 | 808 | 0.040 |
Why?
|
| Sphingosine | 1 | 2020 | 308 | 0.040 |
Why?
|
| Epicardial Mapping | 1 | 2018 | 56 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2003 | 1415 | 0.040 |
Why?
|
| Nuclear Pore | 1 | 2018 | 62 | 0.040 |
Why?
|
| Neprilysin | 1 | 2021 | 471 | 0.040 |
Why?
|
| Infant, Newborn | 3 | 2017 | 26173 | 0.040 |
Why?
|
| Referral and Consultation | 4 | 2017 | 3579 | 0.040 |
Why?
|
| Exons | 4 | 2013 | 2392 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 3415 | 0.040 |
Why?
|
| Ambystoma mexicanum | 1 | 2018 | 51 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 2003 | 2922 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2022 | 633 | 0.040 |
Why?
|
| Proteins | 2 | 2020 | 6026 | 0.040 |
Why?
|
| Prospective Studies | 6 | 2020 | 54108 | 0.040 |
Why?
|
| Denmark | 1 | 2019 | 759 | 0.040 |
Why?
|
| Carotid Artery Diseases | 1 | 2003 | 872 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2020 | 740 | 0.030 |
Why?
|
| Research | 1 | 2005 | 1975 | 0.030 |
Why?
|
| Electron Transport Complex IV | 1 | 2017 | 190 | 0.030 |
Why?
|
| Embryonic Development | 2 | 2013 | 716 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2008 | 4491 | 0.030 |
Why?
|
| Sulfur | 1 | 2017 | 163 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2017 | 223 | 0.030 |
Why?
|
| Gene Duplication | 1 | 2017 | 313 | 0.030 |
Why?
|
| Myxoma | 1 | 1997 | 114 | 0.030 |
Why?
|
| Health Communication | 1 | 2019 | 213 | 0.030 |
Why?
|
| Japan | 1 | 2020 | 1364 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2003 | 1332 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 1996 | 127 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2017 | 184 | 0.030 |
Why?
|
| Avian Proteins | 1 | 1996 | 80 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2007 | 2475 | 0.030 |
Why?
|
| Stress, Mechanical | 2 | 2014 | 1664 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2016 | 5854 | 0.030 |
Why?
|
| Genes | 1 | 2020 | 1844 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 3795 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2020 | 1233 | 0.030 |
Why?
|
| Chromosomes, Mammalian | 1 | 2016 | 146 | 0.030 |
Why?
|
| Liver | 1 | 2011 | 7503 | 0.030 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2015 | 43 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 1996 | 286 | 0.030 |
Why?
|
| Vagotomy | 1 | 2015 | 83 | 0.030 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 2016 | 88 | 0.030 |
Why?
|
| Brazil | 1 | 2019 | 1217 | 0.030 |
Why?
|
| Peptides, Cyclic | 1 | 2018 | 392 | 0.030 |
Why?
|
| Mitral Valve Prolapse | 1 | 1997 | 214 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2015 | 66 | 0.030 |
Why?
|
| Salivary Proteins and Peptides | 1 | 2015 | 48 | 0.030 |
Why?
|
| Electron Transport Complex II | 1 | 2015 | 53 | 0.030 |
Why?
|
| Aging | 2 | 2023 | 8650 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2017 | 327 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2016 | 281 | 0.030 |
Why?
|
| Solubility | 1 | 2017 | 1087 | 0.030 |
Why?
|
| Ectromelia | 1 | 1995 | 28 | 0.030 |
Why?
|
| Biotransformation | 1 | 2015 | 166 | 0.030 |
Why?
|
| Genetic Heterogeneity | 2 | 1997 | 723 | 0.030 |
Why?
|
| Thyroid Neoplasms | 1 | 2008 | 2326 | 0.030 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2016 | 131 | 0.030 |
Why?
|
| Excitation Contraction Coupling | 1 | 2014 | 25 | 0.030 |
Why?
|
| Hominidae | 1 | 1995 | 68 | 0.030 |
Why?
|
| Hemangioblasts | 1 | 2014 | 28 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1995 | 410 | 0.030 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2021 | 1016 | 0.030 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 1997 | 243 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 724 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2019 | 3171 | 0.030 |
Why?
|
| Denervation | 1 | 2015 | 263 | 0.030 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2015 | 183 | 0.030 |
Why?
|
| Protein Binding | 2 | 2020 | 9312 | 0.030 |
Why?
|
| Acute Disease | 2 | 2020 | 7226 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 1503 | 0.030 |
Why?
|
| Somites | 1 | 2014 | 60 | 0.030 |
Why?
|
| Nerve Growth Factor | 1 | 2015 | 158 | 0.030 |
Why?
|
| Pericytes | 1 | 2017 | 293 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2016 | 3432 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 584 | 0.030 |
Why?
|
| Isoproterenol | 1 | 2014 | 394 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2017 | 432 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2022 | 1972 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2015 | 295 | 0.030 |
Why?
|
| Hand Deformities, Congenital | 1 | 1995 | 174 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 1664 | 0.030 |
Why?
|
| Chromosome Aberrations | 2 | 1999 | 1764 | 0.030 |
Why?
|
| Dilatation, Pathologic | 1 | 2015 | 527 | 0.030 |
Why?
|
| England | 2 | 1992 | 523 | 0.030 |
Why?
|
| Troponin | 2 | 1994 | 500 | 0.030 |
Why?
|
| Heart Neoplasms | 1 | 1997 | 360 | 0.030 |
Why?
|
| Infant | 3 | 2017 | 36043 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2024 | 2621 | 0.030 |
Why?
|
| Recombination, Genetic | 2 | 1995 | 1526 | 0.030 |
Why?
|
| Muscle Cells | 1 | 2014 | 194 | 0.030 |
Why?
|
| Molecular Probe Techniques | 1 | 1994 | 111 | 0.030 |
Why?
|
| Eye Proteins | 2 | 2008 | 633 | 0.030 |
Why?
|
| Ribonucleases | 1 | 1994 | 276 | 0.030 |
Why?
|
| Fetal Proteins | 1 | 2013 | 97 | 0.030 |
Why?
|
| Pralidoxime Compounds | 1 | 2012 | 5 | 0.030 |
Why?
|
| Cholinesterase Reactivators | 1 | 2012 | 6 | 0.030 |
Why?
|
| Emetine | 1 | 2012 | 15 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2016 | 544 | 0.030 |
Why?
|
| Proteinuria | 1 | 2016 | 594 | 0.030 |
Why?
|
| Glycopyrrolate | 1 | 2012 | 32 | 0.030 |
Why?
|
| DNA Primers | 4 | 2004 | 2816 | 0.030 |
Why?
|
| Metoclopramide | 1 | 2012 | 51 | 0.030 |
Why?
|
| Health Priorities | 1 | 2016 | 375 | 0.030 |
Why?
|
| Nitroprusside | 1 | 2013 | 272 | 0.030 |
Why?
|
| Certification | 1 | 2016 | 418 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 686 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2014 | 408 | 0.030 |
Why?
|
| Neostigmine | 1 | 2012 | 68 | 0.030 |
Why?
|
| Urinary Tract Physiological Phenomena | 1 | 2012 | 11 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 609 | 0.030 |
Why?
|
| Rats, Inbred BN | 1 | 2012 | 231 | 0.030 |
Why?
|
| Inosine | 1 | 2013 | 130 | 0.030 |
Why?
|
| Cholesterol | 1 | 2021 | 2900 | 0.030 |
Why?
|
| Mesoderm | 1 | 2015 | 672 | 0.030 |
Why?
|
| Pirenzepine | 1 | 2012 | 116 | 0.030 |
Why?
|
| Atropine | 1 | 2012 | 244 | 0.030 |
Why?
|
| Inulin | 1 | 2012 | 68 | 0.030 |
Why?
|
| Neurons | 1 | 2011 | 9419 | 0.030 |
Why?
|
| Contractile Proteins | 1 | 1993 | 240 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1996 | 829 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2021 | 2374 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2016 | 2176 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1993 | 362 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 473 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2013 | 751 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2015 | 1485 | 0.020 |
Why?
|
| Laminin | 1 | 1993 | 405 | 0.020 |
Why?
|
| Disease Progression | 3 | 2019 | 13464 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2022 | 2976 | 0.020 |
Why?
|
| Cholinergic Antagonists | 1 | 2012 | 164 | 0.020 |
Why?
|
| Podocytes | 1 | 2016 | 402 | 0.020 |
Why?
|
| Curriculum | 2 | 2016 | 3715 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2017 | 9624 | 0.020 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 1 | 2011 | 59 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2011 | 6802 | 0.020 |
Why?
|
| Child, Preschool | 4 | 2019 | 42044 | 0.020 |
Why?
|
| Pregnancy | 2 | 2011 | 29720 | 0.020 |
Why?
|
| Inservice Training | 1 | 2014 | 375 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 2013 | 388 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2012 | 825 | 0.020 |
Why?
|
| Circle of Willis | 1 | 2011 | 78 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2015 | 1865 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 2223 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 20039 | 0.020 |
Why?
|
| Bile Acids and Salts | 1 | 2013 | 383 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2005 | 9265 | 0.020 |
Why?
|
| Medical Audit | 1 | 1992 | 452 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2014 | 1084 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2011 | 532 | 0.020 |
Why?
|
| Survival Analysis | 3 | 2014 | 10075 | 0.020 |
Why?
|
| Waiting Lists | 2 | 1992 | 762 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2013 | 1647 | 0.020 |
Why?
|
| Exercise Test | 1 | 2018 | 2121 | 0.020 |
Why?
|
| Endocardial Cushion Defects | 1 | 2009 | 43 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2017 | 1737 | 0.020 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2015 | 393 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 685 | 0.020 |
Why?
|
| Drug Approval | 1 | 2017 | 808 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2023 | 3388 | 0.020 |
Why?
|
| Fruit | 1 | 2015 | 1159 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2001 | 0.020 |
Why?
|
| Skin | 1 | 2003 | 4464 | 0.020 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2009 | 63 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2012 | 676 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2015 | 3593 | 0.020 |
Why?
|
| Utilization Review | 1 | 1991 | 382 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 2646 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2003 | 3047 | 0.020 |
Why?
|
| Iliac Artery | 1 | 2011 | 342 | 0.020 |
Why?
|
| Cell Survival | 2 | 2013 | 5782 | 0.020 |
Why?
|
| Clinical Competence | 2 | 2016 | 4760 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2013 | 1568 | 0.020 |
Why?
|
| Immunity | 1 | 2015 | 997 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2019 | 2970 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2015 | 1593 | 0.020 |
Why?
|
| Losartan | 1 | 2011 | 265 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 1120 | 0.020 |
Why?
|
| Neoplasms | 2 | 2016 | 21990 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 1996 | 1414 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2015 | 1168 | 0.020 |
Why?
|
| Lateral Line System | 1 | 2008 | 11 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3613 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2012 | 694 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2018 | 11470 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 695 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 2387 | 0.020 |
Why?
|
| Endocardium | 1 | 2009 | 246 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2014 | 824 | 0.020 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2015 | 866 | 0.020 |
Why?
|
| Death | 1 | 2013 | 674 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2013 | 1387 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 1501 | 0.020 |
Why?
|
| Tandem Repeat Sequences | 1 | 2009 | 180 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2006 | 12870 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 3734 | 0.020 |
Why?
|
| Physicians, Primary Care | 1 | 2015 | 623 | 0.020 |
Why?
|
| Syncope | 1 | 2011 | 427 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2017 | 4113 | 0.020 |
Why?
|
| RNA | 1 | 2018 | 2716 | 0.020 |
Why?
|
| Point Mutation | 1 | 1993 | 1594 | 0.020 |
Why?
|
| Coronary Vessels | 2 | 2011 | 3072 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2023 | 79982 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2015 | 3967 | 0.020 |
Why?
|
| Health Promotion | 1 | 2019 | 2202 | 0.020 |
Why?
|
| Hong Kong | 1 | 2007 | 167 | 0.020 |
Why?
|
| Iceland | 1 | 2007 | 184 | 0.020 |
Why?
|
| Erythroid Precursor Cells | 1 | 2008 | 211 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2020 | 6198 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2004 | 1991 | 0.020 |
Why?
|
| GATA1 Transcription Factor | 1 | 2008 | 296 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2443 | 0.020 |
Why?
|
| Glucose | 1 | 2018 | 4336 | 0.020 |
Why?
|
| Transfection | 1 | 2014 | 5779 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2010 | 2557 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6469 | 0.020 |
Why?
|
| Genes, Lethal | 1 | 2006 | 225 | 0.020 |
Why?
|
| Heterozygote | 1 | 2013 | 2797 | 0.020 |
Why?
|
| Kidney | 1 | 2002 | 7013 | 0.020 |
Why?
|
| Receptor, TIE-2 | 1 | 2006 | 176 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4567 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 16891 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2009 | 848 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2006 | 426 | 0.020 |
Why?
|
| Phenylephrine | 1 | 2006 | 293 | 0.020 |
Why?
|
| Focus Groups | 1 | 2011 | 1382 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 1667 | 0.020 |
Why?
|
| Consensus | 1 | 2015 | 3098 | 0.020 |
Why?
|
| Recurrence | 1 | 2018 | 8426 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 2836 | 0.020 |
Why?
|
| Hair Cells, Auditory | 1 | 2008 | 379 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 3 | 2006 | 6069 | 0.020 |
Why?
|
| Health Behavior | 1 | 2017 | 2615 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 2870 | 0.020 |
Why?
|
| Angiography | 1 | 2011 | 1600 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2006 | 660 | 0.020 |
Why?
|
| Aortic Valve | 1 | 2015 | 1950 | 0.020 |
Why?
|
| Self-Injurious Behavior | 1 | 2011 | 556 | 0.020 |
Why?
|
| Violence | 1 | 2011 | 934 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2015 | 5411 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2010 | 1996 | 0.020 |
Why?
|
| Internationality | 1 | 2010 | 1000 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 1170 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2010 | 1373 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2014 | 3380 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2015 | 8298 | 0.010 |
Why?
|
| Integrases | 1 | 2006 | 516 | 0.010 |
Why?
|
| Sweden | 1 | 2007 | 1376 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2018 | 3241 | 0.010 |
Why?
|
| Body Size | 1 | 2007 | 462 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2017 | 3234 | 0.010 |
Why?
|
| Erythropoiesis | 1 | 2008 | 682 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 1968 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 3667 | 0.010 |
Why?
|
| Arteriovenous Malformations | 1 | 2006 | 397 | 0.010 |
Why?
|
| Selection Bias | 1 | 2005 | 357 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 2007 | 773 | 0.010 |
Why?
|
| Health Policy | 1 | 2016 | 2675 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 14478 | 0.010 |
Why?
|
| Tunica Media | 1 | 2003 | 112 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2005 | 1543 | 0.010 |
Why?
|
| Medical Errors | 1 | 2011 | 1255 | 0.010 |
Why?
|
| Mice, Transgenic | 2 | 2006 | 9519 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2006 | 1370 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2006 | 923 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 877 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 2010 | 12950 | 0.010 |
Why?
|
| Catecholamines | 1 | 2003 | 385 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1994 | 778 | 0.010 |
Why?
|
| Radiography | 1 | 2013 | 6957 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 1991 | 2187 | 0.010 |
Why?
|
| Myocardial Reperfusion | 1 | 2003 | 337 | 0.010 |
Why?
|
| Mitochondria, Heart | 1 | 2003 | 229 | 0.010 |
Why?
|
| Organ Size | 1 | 2007 | 2248 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 2895 | 0.010 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2005 | 597 | 0.010 |
Why?
|
| Age Distribution | 1 | 2007 | 2875 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2006 | 1133 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2011 | 2018 | 0.010 |
Why?
|
| Tunica Intima | 1 | 2003 | 459 | 0.010 |
Why?
|
| Qualitative Research | 1 | 2011 | 2975 | 0.010 |
Why?
|
| Survival Rate | 2 | 2011 | 12685 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2018 | 4760 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 1674 | 0.010 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 1 | 1999 | 21 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 1121 | 0.010 |
Why?
|
| Family Health | 1 | 2005 | 1256 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 3864 | 0.010 |
Why?
|
| Inpatients | 1 | 2011 | 2536 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 11065 | 0.010 |
Why?
|
| Thyrotropin | 1 | 2003 | 832 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 1996 | 2506 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 3984 | 0.010 |
Why?
|
| Aspirin | 1 | 2011 | 3131 | 0.010 |
Why?
|
| Models, Biological | 1 | 2015 | 9460 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2011 | 2746 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1994 | 14638 | 0.010 |
Why?
|
| Dyspnea | 1 | 2006 | 1344 | 0.010 |
Why?
|
| Monocytes | 1 | 2008 | 2570 | 0.010 |
Why?
|
| Rest | 1 | 2003 | 914 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 5639 | 0.010 |
Why?
|
| Hospitalization | 1 | 2018 | 10633 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2005 | 2675 | 0.010 |
Why?
|
| Anemia | 1 | 2006 | 1503 | 0.010 |
Why?
|
| Fibrinolytic Agents | 1 | 2007 | 2070 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 3603 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2004 | 2666 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 2357 | 0.010 |
Why?
|
| Alagille Syndrome | 1 | 1996 | 45 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1996 | 777 | 0.010 |
Why?
|
| Logistic Models | 1 | 2010 | 13222 | 0.010 |
Why?
|
| Sequence Tagged Sites | 1 | 1995 | 94 | 0.010 |
Why?
|
| Chickens | 1 | 1996 | 859 | 0.010 |
Why?
|
| Receptor, trkA | 1 | 1995 | 159 | 0.010 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 1995 | 198 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 1991 | 5382 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1996 | 2263 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2008 | 3599 | 0.010 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 1995 | 460 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2006 | 14354 | 0.010 |
Why?
|
| Genes, MHC Class I | 1 | 1992 | 240 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2007 | 6457 | 0.010 |
Why?
|
| Private Practice | 1 | 1991 | 152 | 0.010 |
Why?
|
| Massachusetts | 1 | 2003 | 8815 | 0.010 |
Why?
|
| Boston | 1 | 2003 | 9297 | 0.010 |
Why?
|
| State Medicine | 1 | 1991 | 212 | 0.010 |
Why?
|
| Parents | 1 | 2003 | 3548 | 0.010 |
Why?
|
| Oncogenes | 1 | 1995 | 1222 | 0.010 |
Why?
|
| Troponin I | 1 | 1993 | 632 | 0.000 |
Why?
|
| Blood Glucose | 1 | 2003 | 6349 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1996 | 2611 | 0.000 |
Why?
|
| Probability | 1 | 1993 | 2461 | 0.000 |
Why?
|
| Reference Values | 1 | 1995 | 4918 | 0.000 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1995 | 1622 | 0.000 |
Why?
|
| Gene Expression | 1 | 1996 | 7584 | 0.000 |
Why?
|
| Quality of Health Care | 1 | 1991 | 4308 | 0.000 |
Why?
|